Bicycle Therapeutics plc (BCYC)

SEC filing

Bicycle Therapeutics plc

BCYC · CIK 1761612

4 · Oct 6, 2026 · Director, CHIEF EXECUTIVE OFFICER Lee Kevin sold 7,805 shares at $3.49/share ($27,247)

Director, CHIEF EXECUTIVE OFFICER Lee Kevin sold 7,805 shares at $3.49/share ($27,247)

xslF345X06/form4-10062026_041001.xml

xslF345X06/form4-10062026_041001.xmlSEC.gov

Graphics and non-inline formats (not embedded below).